B of A Securities Reiterates Sell Rating on ICON Public Limited Company
B of A Securities maintains a sell rating on ICON PLC with a $150 price target, a 11.69% downside from the current price.
Key Points
- B of A Securities reiterated its sell rating on ICON Public Limited Company (ICLR) with a price target of $150.
- B of A Securities's $150 price target implies 11.69% downside from ICON Public Limited Company's ($ICLR) current $169.86 share price.
- ICON shares traded at $158.17 on Thursday, with a market cap of approximately $10.78 billion and a forward P/E of 12.03.
- Several insiders, including Dr. John Climax, engaged in buying and selling shares on May 14, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
B of A Securities reiterated its sell rating on ICON Public Limited Company (NASDAQ: ICLR) on June 25, 2026. The firm, represented by analyst Michael Ryskin, set a price target of $150. Shares of ICON traded at $158.17 on Thursday.
B of A Securities vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
ICON Public Limited Company Stock Down 0.1%
Shares of ICON Public Limited Company traded near $158.17 on Thursday. The company has a market cap of about $10.78 billion and a P/E ratio of 48.36. Its forward P/E is 12.03, and it has a beta of 1.271, indicating some volatility compared to the market. The 52-week range for ICON's stock is between $66.57 and $211.00, with a 50-day moving average of $124.49 and a 200-day moving average of $149.71.
$ICLR price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at ICON Public Limited Company
Several insiders were active in trading ICON shares on May 14, 2026. Dr. John Climax bought and sold 5,005 shares, while Ronan Martin Murphy also participated in similar transactions. Eugene Pacelli McCague was involved in buying and selling 3,255 shares.
Analysts Set New Price Targets
On June 25, 2026, B of A Securities maintained its sell rating on ICON with a $150 price target. Baird also maintained its buy rating with a target of $186. Barclays kept a hold rating with a $160 target on June 24. The consensus among 16 analysts is a buy rating with an average target price of $154.19.
About ICON Public Limited Company
ICON Public Limited Company is a clinical research organization based in Dublin, Ireland. It offers development and commercialization services to the healthcare industry, including pharmaceutical, biotechnology, and medical device sectors. The company supports various stages of clinical development, from early-phase trials to post-market commercialization. ICON employs around 40,100 people and is led by CEO Barry Balfe.
Bottom Line
B of A Securities' reiterated sell rating on ICON highlights the firm's cautious stance despite the company's broad service offerings in the clinical research space. ICON's stock has shown volatility, with a significant 52-week range. Investors should consider this 13F filing as a historical snapshot of analyst sentiment and not necessarily indicative of future performance.
Get ICON Public Limited Company alerts
New 13F filings, insider trades, and analyst moves on $ICLR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.